Literature DB >> 12556646

Results of the ALLHAT trial: is the debate about initial antihypertensive drug therapy over?

Marvin Moser.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12556646      PMCID： PMC8099297          DOI： 10.1111/j.1524-6175.2003.02259.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN： 1524-6175            Impact factor:   3.738


× No keyword cloud information.
  34 in total

1.  Success and predictors of blood pressure control in diverse North American settings: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT).

Authors:  William C Cushman; Charles E Ford; Jeffrey A Cutler; Karen L Margolis; Barry R Davis; Richard H Grimm; Henry R Black; Bruce P Hamilton; Joanne Holland; Chuke Nwachuku; Vasilios Papademetriou; Jeffery Probstfield; Jackson T Wright; Michael H Alderman; Robert J Weiss; Linda Piller; Judy Bettencourt; Sandra M Walsh
Journal:  J Clin Hypertens (Greenwich)       Date:  2002 Nov-Dec       Impact factor: 3.738

2.  Cardiotoxicity and diuretics: much speculation--little substance.

Authors:  G T McInnes; W W Yeo; L E Ramsay; M Moser
Journal:  J Hypertens       Date:  1992-04       Impact factor: 4.844

Review 3.  Suppositions and speculations--their possible effects on treatment decisions in the management of hypertension.

Authors:  M Moser
Journal:  Am Heart J       Date:  1989-12       Impact factor: 4.749

Review 4.  Recent evidence on drug therapy of mild to moderate hypertension and decreased risk of coronary heart disease.

Authors:  P R Hebert; M Moser; J Mayer; R J Glynn; C H Hennekens
Journal:  Arch Intern Med       Date:  1993-03-08

Review 5.  The treatment of hypertension in diabetic patients.

Authors:  M Moser; H Ross
Journal:  Diabetes Care       Date:  1993-02       Impact factor: 19.112

6.  Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy.

Authors:  B M Brenner; M E Cooper; D de Zeeuw; W F Keane; W E Mitch; H H Parving; G Remuzzi; S M Snapinn; Z Zhang; S Shahinfar
Journal:  N Engl J Med       Date:  2001-09-20       Impact factor: 91.245

7.  Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). ALLHAT Collaborative Research Group.

Authors: 
Journal:  JAMA       Date:  2000-04-19       Impact factor: 56.272

8.  The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure.

Authors: 
Journal:  Arch Intern Med       Date:  1997-11-24

9.  Prevention of disease progression, left ventricular hypertrophy and congestive heart failure in hypertension treatment trials.

Authors:  M Moser; P R Hebert
Journal:  J Am Coll Cardiol       Date:  1996-04       Impact factor: 24.094

Review 10.  Diuretics revisited--again.

Authors:  M Moser
Journal:  J Clin Hypertens (Greenwich)       Date:  2001 May-Jun       Impact factor: 3.738
View more
  2 in total

1.  Here we go again.

Authors:  Marvin Moser
Journal:  J Clin Hypertens (Greenwich)       Date:  2003 Mar-Apr       Impact factor: 3.738

Review 2.  Managing high-risk patients with hypertension: focus on the renin-angiotensin system.

Authors:  Alan H Gradman
Journal:  J Clin Hypertens (Greenwich)       Date:  2004-09       Impact factor: 3.738
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.